Alan R. Lehmann

Brighton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Central Nervous System Tumors in Xeroderma Pigmentosum: Five Cases and Review of the Literature.

Central Nervous System Tumors in Xeroderma Pigmentosum: Five Cases and Review of the Literature.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: December 27, 2025

XP-J, a ninth xeroderma pigmentosum complementation group, results from mutations in GTF2H4, encoding TFIIH-p52 subunit.

XP-J, a ninth xeroderma pigmentosum complementation group, results from mutations in GTF2H4, encoding TFIIH-p52 subunit.

Journal: The Journal of clinical investigation

Published: September 09, 2025

Unusual Disease-Progression in Two Siblings With Xeroderma Pigmentosum Group G.

Unusual Disease-Progression in Two Siblings With Xeroderma Pigmentosum Group G.

Journal: Clinical genetics

Published: August 27, 2025

TFIIH-p52ΔC defines a ninth xeroderma pigmentosum complementation-group XP-J and restores TFIIH stability to p8-defective trichothiodystrophy.

TFIIH-p52ΔC defines a ninth xeroderma pigmentosum complementation-group XP-J and restores TFIIH stability to p8-defective trichothiodystrophy.

Journal: The Journal of clinical investigation

Published: May 23, 2025

A Splicing Variant in XPA Results in Delayed Onset of Clinical Features of Xeroderma Pigmentosum.

A Splicing Variant in XPA Results in Delayed Onset of Clinical Features of Xeroderma Pigmentosum.

Journal: The Journal of investigative dermatology

Published: April 11, 2025

Clinical and molecular overlap between nucleotide excision repair (NER) disorders and DYRK1A haploinsufficiency syndrome.

Clinical and molecular overlap between nucleotide excision repair (NER) disorders and DYRK1A haploinsufficiency syndrome.

Journal: Frontiers in neuroscience

Published: December 31, 2024

Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell system.

Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell system.

Journal: Cell reports

Published: July 27, 2023

Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin Compaction.

Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin Compaction.

Journal: The Journal of investigative dermatology

Published: June 21, 2023

Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.

Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.

Journal: Brain : a journal of neurology

Published: February 21, 2023

The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne Syndrome.

The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne Syndrome.

Journal: Pediatric neurology

Published: November 08, 2022

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients.

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients.

Journal: Nature communications

Published: October 18, 2022

Metronidazole-Induced Hepatitis in a Teenager With Xeroderma Pigmentosum and Trichothiodystrophy Overlap.

Metronidazole-Induced Hepatitis in a Teenager With Xeroderma Pigmentosum and Trichothiodystrophy Overlap.

Journal: Pediatrics

Published: June 15, 2021

Showing 1-12 of 60

Last Updated: 09/26/2026